Skip to main content
. 2021 Jan 29;13(12):1073–1080. doi: 10.1136/neurintsurg-2020-016680

Figure 2.

Figure 2

Forest plot of summary odds ratios for sICH in patients with and without adjunctive administration of IAF during MT with strata of IVT before MT. (A) With intravenous tPA (IVT) before MT. (B) Without IVT MT. *For Anadani et al we used PH2 as sICH surrogate. IAF, intra-arterial fibrinolytics; IVT, intravenous thrombolysis; MT, mechanical thrombectomy; PH2, parenchymal hematoma type 2; sICH, symptomatic intracranial hemorrhage; tPA, tissue plasminogen activator; uPA, urokinase.